The Phenotype of the Cryptococcus-Specific CD4(+) Memory T-Cell Response Is Associated With Disease Severity and Outcome in HIV-Associated Cryptococcal Meningitis

por Jarvis, Joseph N., Casazza, Joseph P., Stone, Hunter H., Meintjes, Graeme, Lawn, Stephen D., Levitz, Stuart M., Harrison, Thomas S., Koup, Richard A.
Publicado 2013

Autocrine Production of β-Chemokines Protects CMV-Specific CD4(+) T Cells from HIV Infection

por Casazza, Joseph P., Brenchley, Jason M., Hill, Brenna J., Ayana, Ribka, Ambrozak, David, Roederer, Mario, Douek, Daniel C., Betts, Michael R., Koup, Richard A.
Publicado 2009

PD-1 is a regulator of virus-specific CD8(+) T cell survival in HIV infection

por Petrovas, Constantinos, Casazza, Joseph P., Brenchley, Jason M., Price, David A., Gostick, Emma, Adams, William C., Precopio, Melissa L., Schacker, Timothy, Roederer, Mario, Douek, Daniel C., Koup, Richard A.
Publicado 2006

Acquisition of direct antiviral effector functions by CMV-specific CD4(+) T lymphocytes with cellular maturation

por Casazza, Joseph P., Betts, Michael R., Price, David A., Precopio, Melissa L., Ruff, Laura E., Brenchley, Jason M., Hill, Brenna J., Roederer, Mario, Douek, Daniel C., Koup, Richard A.
Publicado 2006

Selective Loss of Early Differentiated, Highly Functional PD1(high) CD4 T Cells with HIV Progression

por Paris, Robert M., Petrovas, Constantinos, Ferrando-Martinez, Sara, Moysi, Eirini, Boswell, Kristin L., Archer, Eva, Yamamoto, Takuya, Ambrozak, David, Casazza, Joseph P., Haubrich, Richard, Connors, Mark, Ake, Julie, Kim, Jerome H., Koup, Richard A.
Publicado 2015

Preferential infection and depletion of Mycobacterium tuberculosis–specific CD4 T cells after HIV-1 infection

por Geldmacher, Christof, Ngwenyama, Njabulo, Schuetz, Alexandra, Petrovas, Constantinos, Reither, Klaus, Heeregrave, Edwin J., Casazza, Joseph P., Ambrozak, David R., Louder, Mark, Ampofo, William, Pollakis, Georgios, Hill, Brenna, Sanga, Erica, Saathoff, Elmar, Maboko, Leonard, Roederer, Mario, Paxton, William A., Hoelscher, Michael, Koup, Richard A.
Publicado 2010

HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects

por Gach, Johannes S., Gorlani, Andrea, Dotsey, Emmanuel Y., Becerra, Juan C., Anderson, Chase T. M., Berzins, Baiba, Felgner, Philip L., Forthal, Donald N., Deeks, Steven G., Wilkin, Timothy J., Casazza, Joseph P., Koup, Richard A., Katlama, Christine, Autran, Brigitte, Murphy, Robert L., Achenbach, Chad J.
Publicado 2016

Activation and lysis of human CD4 cells latently infected with HIV-1

por Pegu, Amarendra, Asokan, Mangaiarkarasi, Wu, Lan, Wang, Keyun, Hataye, Jason, Casazza, Joseph P., Guo, Xiaoti, Shi, Wei, Georgiev, Ivelin, Zhou, Tongqing, Chen, Xuejun, O'Dell, Sijy, Todd, John-Paul, Kwong, Peter D., Rao, Srinivas S., Yang, Zhi-yong, Koup, Richard A., Mascola, John R., Nabel, Gary J.
Publicado 2015

Application of B cell immortalization for the isolation of antibodies and B cell clones from vaccine and infection settings

por Boswell, Kristin L., Watkins, Timothy A., Cale, Evan M., Samsel, Jakob, Andrews, Sarah F., Ambrozak, David R., Driscoll, Jefferson I., Messina, Michael A., Narpala, Sandeep, Hopp, Christine S., Cagigi, Alberto, Casazza, Joseph P., Yamamoto, Takuya, Zhou, Tongqing, Schief, William R., Crompton, Peter D., Ledgerwood, Julie E., Connors, Mark, Gama, Lucio, Kwong, Peter D., McDermott, Adrian, Mascola, John R., Koup, Richard A.
Publicado 2022

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults

por Minassian, Angela M, Rowland, Rosalind, Beveridge, Natalie E R, Poulton, Ian D, Satti, Iman, Harris, Stephanie, Poyntz, Hazel, Hamill, Matthew, Griffiths, Kristin, Sander, Clare R, Ambrozak, David R, Price, David A, Hill, Brenna J, Casazza, Joseph P, Douek, Daniel C, Koup, Richard A, Roederer, Mario, Winston, Alan, Ross, Jonathan, Sherrard, Jackie, Rooney, Guy, Williams, Nicola, Lawrie, Alison M, Fletcher, Helen A, Pathan, Ansar A, McShane, Helen
Publicado 2011

Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections

por Promsote, Wanwisa, Xu, Ling, Hataye, Jason, Fabozzi, Giulia, March, Kylie, Almasri, Cassandra G., DeMouth, Megan E., Lovelace, Sarah E., Talana, Chloe Adrienna, Doria-Rose, Nicole A., McKee, Krisha, Hait, Sabrina Helmold, Casazza, Joseph P., Ambrozak, David, Beninga, Jochen, Rao, Ercole, Furtmann, Norbert, Birkenfeld, Joerg, McCarthy, Elizabeth, Todd, John-Paul, Petrovas, Constantinos, Connors, Mark, Hebert, Andrew T., Beck, Jeremy, Shen, Junqing, Zhang, Bailin, Levit, Mikhail, Wei, Ronnie R., Yang, Zhi-yong, Pegu, Amarendra, Mascola, John R., Nabel, Gary J., Koup, Richard A.
Publicado 2023